Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Retatrutide seems to help with more weight loss than semaglutide
Some researchers explore microdosing tirzepatide at levels below the standard starting dose, though this approach falls outside typical prescribing guidelines
Adhesive patch side effects are typically mild and localized
Suitable for clinics, pharmacies, hospitals, medical offices, and healthcare settings under professional direction
It was approved by the FDA in April 2026 as the first oral GLP-1 agonist that does not require absorption enhancers or food restrictions
US$ 22.55
US$ 20.51
US$ 25.82
